Evaluation of the aptima HIV-1 Quant Dx assay for HIV-1 RNA quantitation in different biological specimen types

Journal of Clinical Microbiology

Volumn 55, Issue 8, 2017, Pages 2544-2553

  Yek, Christina ^a,f   Massanella, Marta ^a,g   Peling, Tashi ^b   Lednovich, Kristen ^b   Nair, Sangeetha V ^b   Worlock, Andrew ^b   Vargas, Milenka ^a   Gianella, Sara ^a   Ellis, Ronald J ^a   Strain, Matthew C ^a   Busch, Michael P ^c,d   Nugent, C Thomas ^b,h   Richman, Douglas D ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOLOGIC INC   (United States)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^h Banyan Biomarkers   (United States)

Author keywords

Assay development; Cerebrospinal fluid; Dried blood spots; Dried plasma spots; Human immunodeficiency virus; Peripheral blood mononuclear cells; Plasma; Semen

Indexed keywords

VIRUS RNA;

ARTICLE; AUTOMATION; BLOOD CHEMISTRY; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIAGNOSTIC KIT; DRIED BLOOD SPOT TESTING; DRIED PLASMA SPOT; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA ANALYSIS; SEMINAL PLASMA; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; EVALUATION STUDY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LABORATORY AUTOMATION; PROCEDURES; VIRUS LOAD;

AUTOMATION, LABORATORY; HIV-1; HUMANS; RNA, VIRAL; VIRAL LOAD;

EID: 85026270691     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00425-17     Document Type: Article

References (26)

1. Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA. 2006. The survival benefits of AIDS treatment in the United States. J Infect Dis 194:11-19. https://doi.org/ 10.1086/505147.
2. Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, Markowitz M, Ho DD. 1997. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387:188-191. https://doi .org/10.1038/387188a0.
3. Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J, Siliciano RF. 1999. Latent infection of CD4-T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 5:512-517. https://doi.org/10.1038/8394.
4. Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. 2009. The challenge of finding a cure for HIV infection. Science 323:1304-1307. https://doi.org/10.1126/science.1165706.
5. Eisele E, Siliciano RF. 2012. Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity 37:377-388. https://doi.org/10.1016/j.immuni.2012 .08.010.
6. Massanella M, Richman DD. 2016. Measuring the latent reservoir in vivo. J Clin Invest 126:464-472. https://doi.org/10.1172/JCI80567.
7. Shao Y, Williamson C. 2012. The HIV-1 epidemic: low-to middle-income countries. Cold Spring Harb Perspect Med 2:a007187. https://doi.org/10 .1101/cshperspect.a007187.
8. Hamers RL, Smit PW, Stevens W, Schuurman R, Rinke de Wit TF. 2009. Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir Ther 14:619-629.
9. Bertagnolio S, Parkin NT, Jordan M, Brooks J, Garcia-Lerma JG. 2010. Dried blood spots for HIV-1 drug resistance and viral load testing: a review of current knowledge and WHO efforts for global HIV drug resistance surveillance. AIDS Rev 12:195-208.
10. Kacian DL, Fultz TJ. March 1995. Nucleic acid sequence amplification methods.US patent 5399491.
11. Nair SV, Kim HC, Fortunko J, Foote T, Peling T, Tran C, Nugent CT, Joo S, Kang Y, Wilkins B, Lednovich K, Worlock A. 2016. Aptima HIV-1 Quant Dx-A fully automated assay for both diagnosis and quantification of HIV-1. J Clin Virol 77:46-54. https://doi.org/10.1016/j.jcv.2016.02.002.
12. Gianella S, Strain MC, Rought SE, Vargas MV, Little SJ, Richman DD, Spina CA, Smith DM. 2012. Associations between virologic and immunologic dynamics in blood and in the male genital tract. J Virol 86:1307-1315. https://doi.org/10.1128/JVI.06077-11.
13. Mor O, Gozlan Y, Wax M, Mileguir F, Rakovsky A, Noy B, Mendelson E, Levy I. 2015. Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx assays in comparison to the NucliSens EasyQ HIV-1 v20 assay for quantification of HIV-1 viral load. J Clin Microbiol 53: 3458-3465. https://doi.org/10.1128/JCM.01806-15.
14. Schalasta G, Borner A, Speicher A, Enders M. 2016. Comparative evaluation of the Aptima HIV-1 Quant Dx assay and COBAS TaqMan HIV-1 v2.0 assay using the Roche High Pure system for the quantification of HIV-1 RNA in plasma. Clin Chem Lab Med 54:493-499. https://doi.org/10.1515/ cclm-2015-0522.
15. Canestri A, Lescure FX, Jaureguiberry S, Moulignier A, Amiel C, Marcelin AG, Peytavin G, Tubiana R, Pialoux G, Katlama C. 2010. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis 50:773-778. https://doi.org/10.1086/650538.
16. Dyer JR, Gilliam BL, Eron JJ, Jr, Grosso L, Cohen MS, Fiscus SA. 1996. Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture. J Virol Methods 60:161-170. https://doi.org/10.1016/0166-0934 (96)02063-0.
17. Shepard RN, Schock J, Robertson K, Shugars DC, Dyer J, Vernazza P, Hall C, Cohen MS, Fiscus SA. 2000. Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol 38:1414-1418.
18. Cillo AR, Sobolewski MD, Bosch RJ, Fyne E, Piatak M, Jr, Coffin JM, Mellors JW. 2014. Quantification of HIV-1 latency reversal in resting CD4+T cells from patients on suppressive antiretroviral therapy. Proc Natl Acad Sci U S A 111:7078-7083. https://doi.org/10.1073/pnas .1402873111.
19. Nugent CT, Dockter J, Bernardin F, Hecht R, Smith D, Delwart E, Pilcher C, Richman D, Busch M, Giachetti C. 2009. Detection of HIV-1 in alternative specimen types using the APTIMA HIV-1 RNA qualitative assay. J Virol Methods 159:10-14. https://doi.org/10.1016/j.jviromet.2009.02.015.
20. Smit PW, Sollis KA, Fiscus S, Ford N, Vitoria M, Essajee S, Barnett D, Cheng B, Crowe SM, Denny T, Landay A, Stevens W, Habiyambere V, Perriens JH, Peeling RW. 2014. Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis. PLoS One 9:e86461. https://doi.org/10.1371/journal.pone.0086461.
21. Phillips A, Shroufi A, Vojnov L, Cohn J, Roberts T, Ellman T, Bonner K, Rousseau C, Garnett G, Cambiano V, Nakagawa F, Ford D, Bansi-Matharu L, Miners A, Lundgren JD, Eaton JW, Parkes-Ratanshi R, Katz Z, Maman D, Ford N, Vitoria M, Doherty M, Dowdy D, Nichols B, Murtagh M, Wareham M, Palamountain KM, Chakanyuka Musanhu C, Stevens W, Katzenstein D, Ciaranello A, Barnabas R, Braithwaite RS, Bendavid E, Nathoo KJ, van de Vijver D, Wilson DP, Holmes C, Bershteyn A, Walker S, Raizes E, Jani I, Nelson LJ, Peeling R, Terris-Prestholt F, Murungu J, Mutasa-Apollo T, Hallett TB, Revill P. 2015. Sustainable HIV treatment in Africa through viral-load-informed differentiated care. Nature 528:S68-S76. https://doi .org/10.1038/nature16046.
22. Jackson JB, Smith K, Knott C, Korpela A, Simmons A, Piwowar-Manning E, McDonough S, Mimms L, Vargo JM. 2002. Sensitivity of the Procleix HIV-1/HCV assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA in a high-risk population. J Clin Microbiol 40:2387-2391. https://doi.org/10.1128/JCM.40.7.2387-2391.2002.
23. Giachetti C, Linnen JM, Kolk DP, Dockter J, Gillotte-Taylor K, Park M, Ho-Sing-Loy M, McCormick MK, Mimms LT, McDonough SH. 2002. Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 40:2408-2419. https://doi.org/10.1128/JCM.40.7.2408-2419.2002.
24. Koppelman MH, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, Lelie PN, Cuypers HT. 2005. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations. Transfusion 45:1258-1266. https://doi .org/10.1111/j.1537-2995.2005.00197.x.
25. Rodriguez-Alfageme C, Chen Z, Sonoda G, Testa JR, Damiani RD, Astrin SM. 1998. B cells malignantly transformed by human immunodeficiency virus are polyclonal. Virology 252:34-38. https://doi.org/10.1006/viro.1998.9445.
26. Little SJ, Frost SD, Wong JK, Smith DM, Pond SL, Ignacio CC, Parkin NT, Petropoulos CJ, Richman DD. 2008. Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol 82:5510-5518. https://doi.org/10.1128/JVI.02579-07.